I like getting a sense of what we can expect (or more) once Leronlimab is approved mid 2020. Here's an example from today...

Intra-Cellular Therapies (ITCI) got approval today for their antipsychotic drug, Caplyta, and the stock went up 194%. And that's with sales not even starting until late 1st quarter 2020.

Let's get the BLA submitted, and more Cancer data stat!!